Skip to content

Drug interactions

Larotrectinib + Sorafenib

Severity: Minor

Larotrectinib and Sorafenib: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Larotrectinib is a CYP3A4 substrate and a weak CYP3A4 inhibitor, so it may slightly increase sorafenib exposure. The clinical impact is likely limited.

What this interaction means in plain words

Larotrectinib and Sorafenib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Larotrectinib belongs to Oncology; Sorafenib belongs to Oncology.

Evidence level: Low

Why it happens

Weak CYP3A4 inhibition by larotrectinib reduces sorafenib metabolism.

What to do

No routine dose change is needed. Monitor tolerability of sorafenib.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Larotrectinib and Sorafenib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Larotrectinib with Sorafenib?

MediHelp rates the interaction as minor. Larotrectinib and Sorafenib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Larotrectinib is a CYP3A4 substrate and a weak CYP3A4 inhibitor, so it may slightly increase sorafenib exposure. The clinical impact is likely limited.

How serious is the interaction between Larotrectinib and Sorafenib?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine dose change is needed. Monitor tolerability of sorafenib.

What other medicines interact with Sorafenib?

MediHelp also lists interactions of Sorafenib with, for example, Adagrasib, Amiodarone, Amisulpride. The full list is on the Sorafenib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in